Pfizer Limited reports a change in its board or management
In short
Pfizer Limited informed the NSE on August 22, 2026, about a change in directors, KMP, SMP, auditor or RTA. No figures, breakdowns, scheme names, or closing dates are given in the text. In simple terms, the company is reporting a management or corporate-appointment update, but the notice does not say who changed or what was appointed, so there is no practical detail to summarize. No validity period or deadline is stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.